Effective November 2015
**Not accepting Catalyst Funding applications for the Spring 2016 round of funding**
To assist investigators in establishing new and exciting research programs that take advantage of the core platforms of excellence across the SOM, a catalyst/seed funding mechanism has been developed.
A. COLLABORATION: To enhance cross-disciplinary interactions, multi-investigator seed programs that foster/demonstrate interactions across signature programs (Emory Medicine Skyline) of excellence and/or research platforms are encouraged but not necessary.
B. FUNDING NEED: Eligible applicants must have less than $500,000 (per investigator, if a joint application) in total available direct dollars.
II. Application Procedure
Applications will be accepted for deadlines of April 15 and December 15, and should be submitted by the investigator’s department chair as an electronic, single pdf, in the order listed below to Trish Haugaard (firstname.lastname@example.org) in the Office of the Executive Associate Dean for Research.
A. A letter (2 pages maximum) from the investigator(s) using the following organization to explain:
A.1. Project Title.
A.2. Significance and Innovation associated with the proposed project, long term goals, and potential scientific/medical outcomes associated with project
A.3. BUDGET: A proposed budget for use of the catalyst funds, including names and roles for the personnel. *Note that the School’s seed funds cannot be used for salary support of the PI or co-PIs, for travel, or equipment.
A.4. Dollar amounts (direct funding) available from ALL sources, source type, and number, your role, and their ending dates (for each applicant if a joint proposal). If none, state none. Please list (see examples below):
$250,000, NIH R01 AI34000, PI, 12-31-2017;
$75,000, Dept Interim funding, PI, no end date;
$65,000, American Heart Association, co-PI, 1-15-18;
$35,000, So-in-so endowed professorship, PI no end date, salary only, etc.
A.5. List of pending grant applications in the above format. Indicate whether or not this current plan is in the pending applications (for each applicant if a joint proposal).
A.6. Plan for submission of work for extramural funding
A.7. The author, title, journal and reference of five articles that the applicant considers to be the most significant, recent contributions (for each applicant if a joint proposal).
A.8. A statement that any remaining seed funds will be relinquished as soon as funding for this project is secured.
B. Project Description
B.1. Specific Aims style page for this project (1 page max)
B.2. Brief Approach (1 page max). Include large overview of the plan not included in B.1.
C. CVs of the PIs
D. A separate, confidential letter (pdf) should be prepared from the investigator's chair and sent directly to the Executive Associate Dean of Research c/o Trish Haugaard. This is a confidential letter that only the leadership team making the final funding decisions will read (this letter should not be included in the applicant’s packet). (If a joint application submit a letter signed by the respective department chairs). The letter should include the following:
D.1. confirming the amount of the request;
D.2. indicating the degree of departmental enthusiasm for the investigator(s);
D.3. stating that the investigator does not have other monies to draw on; this would include any discretionary account.
D.4. whether the investigator would benefit from mentoring and if so the outline of a plan;
D.5. whether additional departmental funds are available to pool with institutional seed funds. Departmental matching funds are strongly encouraged but might not be possible in all situations.
III. Selection and Funding Procedures
A committee of seasoned investigators will review applications and recommend action, recognizing that sufficient funds are unlikely to be available to support all applicants. Decisions will be made in consultation with the Dean, the EAD-Research office, and WHSC VP-Research. Work funded under this mechanism must meet all regulatory requirements of Emory University School of Medicine. Funds unexpended within 15 months of the initial payment will be relinquished.
One year after the end of the catalyst and seed funding award the faculty member and departmental chair will prepare a brief letter to the Executive Associate Dean Research describing the outcome of the award.